CSF3 and graft versus host disease: H&E staining confirmed that relatively less pathological damage in GVHD target organs in recipients transplanted with WT G-CSF-treated donor CD8+CD44−CD62L+ T cells, whereas G-CSF-treated donor PD-1−/− cells caused more severe damages (Fig. 6g).